... and inflammation, and crucial in the management of anemia in patients undergoing hemodialysis – and all-cause mortality. This study aimed to clarify the nuanced relationship between these biomarkers and mortality outcomes, addressing the limitations of traditional cutoff-based analyses. Methods: We conducted...

...Mayuko Hori; Hiroshi Takahashi; Chika Kondo; Asami Takeda; Kunio Morozumi; Shoichi Maruyama Introduction: Zinc, an essential trace element, plays an important role in various cellular processes, and zinc deficiency is common in patients undergoing hemodialysis. Zinc has been shown to stimulate...

... in hemodialysis (HD), symptom-based assessments may be biased, leading to varying results. Surprisingly, no direct comparison of dry weight changes between PD and HD has been conducted. This study aimed to evaluate the impact of transitioning from PD to HD on body weight and related clinical parameters. Methods...

... ischemia during intermittent hemodialysis (IHD) and thereby decrease the incidence and/or intensity of intradialytic muscle cramps. We aimed to test whether angiotensin II infusion during IHD is safe, feasible, and effective in the attenuation of muscle cramps. Methods: We performed a pilot, single-blinded...

...Hoon Yu; Sung Jin Kim; Yoonjong Bae; Mina Kim; Chan-Young Jung Introduction: Although both patients with kidney failure (KF) receiving hemodialysis (HD) and kidney transplantation (KT) recipients (KTRs) have a high risk of bladder cancer, how this risk changes in the transition from dialysis to KT...

... Data Registry. Adult patients who started receiving hemodialysis in 2007 and had a permanent VA created were included. The exposure of interest was the timing of VA creation, categorized into three groups: early VA creation (defined as creation at least 4 months before hemodialysis initiation), just...

...Rachel M. Holden; Patrick A. Norman; Andrew G. Day; Samuel A. Silver; Kristen K. Clemens; Eduard Iliescu Introduction: Vitamin D insufficiency is common in patients who receive hemodialysis, yet there is no clear guidance regarding surveillance or treatment. We hypothesized that increasing 25(OH)D...

...Bróna M. Moloney; Glenn Matthew Chertow; Finnian R. Mc Causland Introduction: Diabetes mellitus is a common cause of kidney failure and is often complicated by autonomic neuropathy, which may have implications for blood pressure (BP) homeostasis during hemodialysis (HD). Methods: In this post hoc...

..., instructions or products referred to in the content or advertisements. 2024 Visual Abstract Center for medicare and medicaid services ESRD prospective payment system Hemodialysis Kidney allograft failure Peritoneal dialysis Peritoneal dialysis (PD) has received significant...

...Seok Hui Kang; Bo Yeon Kim; Eun Jung Son; Gui Ok Kim; Jun Young Do Introduction: There were insufficient pieces of evidence regarding the effect of the two drugs (allopurinol and febuxostat) on patient survival in hemodialysis (HD) patients. Herein, we aimed to compare the efficacy of uric acid...

... dialysis (AKI-D) who were ambulatory and still dependent on hemodialysis (HD) to receive treatment in outpatient dialysis facilities. This policy change generated the ongoing need to improve AKI-D care in the outpatient setting. Methods: Quality improvement study in adult patients admitted to an outpatient...

... ; 32 ( 6 ): 1465 – 73 . 9. Block GA , Rosenbaum DP , Yan A , Chertow GM . Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis: a randomized phase 3 trial . J Am Soc Nephrol . 2019 ; 30 ( 4 ): 641 – 52 . 10. Chiu...

... events and mortality and the influence of ambulatory BP and other cardiovascular risk factors on these associations. Methods: 242 hemodialysis patients with valid 48-h ABPM (Mobil-O-Graph-NG) were followed for a median of 45.7 months. IDHTN was defined as: systolic BP (SBP) rise ≥10 mm Hg from pre...

... and adverse cardiovascular events in hemodialysis patients, the safety of extremely low-dose ESA is unclear. Methods: We retrospectively analyzed the association between ESA dose and mortality in the monthly dosing range of 0–43,000 U of equivalent epoetin alfa in 304 Taiwan hemodialysis patients by using Cox...

... elderly patients (≥75 years). We examined the characteristics of very elderly patients starting hemodialysis (HD) and the associated mortality and prognostic factors. Methods: Data were analyzed retrospectively using a nationwide cohort registry, the Korean Renal Data System. Patients who started HD...

...Panagiotis Theofilis; Aikaterini Vordoni; Rigas G. Kalaitzidis Background: Individuals with end-stage renal disease on chronic hemodialysis (HD) may encounter numerous HD-associated complications, including intradialytic hypertension (IDHYPER). Although blood pressure (BP) follows a predictable...

... in the pathogenesis of vascular calcification, but few studies have examined the association between sclerostin and mortality in hemodialysis patients. Methods: We analyzed a prospective cohort of 654 patients undergoing maintenance hemodialysis. The primary exposure variable was the baseline serum sclerostin level...

... are the most common cause of death in hemodialysis. Autonomic dysfunction plays a central role in this arrhythmogenic background. Previous studies on hemodialysis-related changes in heart rate variability (HRV) give contradictory results. This study investigated HRV indices both at rest and in response...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. COVID-19 Hemodialysis Vaccination Humoral response Estimated marginal means of IgG anti-S titers were analyzed using the general linear model (repeated measures...

...Bruno Legendre; Thierry Lobbedez; Cécile Couchoud; Mathilde Lassalle; Isabelle Kazes; Antoine Lanot; Annabel Boyer; Clémence Béchade Introduction: Switch from hemodialysis (HD) to peritoneal dialysis (PD) is unfrequent, but incentive strategies to perform PD can lead to an increase...